{"id":92,"date":"2026-02-03T17:50:52","date_gmt":"2026-02-03T16:50:52","guid":{"rendered":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html"},"modified":"2026-02-03T17:50:53","modified_gmt":"2026-02-03T16:50:53","slug":"suhagra","status":"publish","type":"post","link":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html","title":{"rendered":"Suhagra"},"content":{"rendered":"<p><html><br \/>\n<body><\/p>\n<p>Le <strong>Suhagra<\/strong> est un m\u00e9dicament g\u00e9n\u00e9rique largement utilis\u00e9 pour traiter la <em>dysfonction \u00e9rectile<\/em> chez les hommes. Compos\u00e9 principal de <strong>sild\u00e9nafil citrate<\/strong>, il agit en am\u00e9liorant le flux sanguin vers le p\u00e9nis, facilitant ainsi l&#8217;obtention et le maintien d&#8217;une \u00e9rection. Cet article explore en d\u00e9tail son profil de s\u00e9curit\u00e9, les aspects li\u00e9s \u00e0 l&#8217;achat en ligne, ainsi que toutes les informations essentielles pour un usage inform\u00e9 et s\u00e9curis\u00e9.<\/p>\n<h2>Qu&#8217;est-ce que Suhagra et pour quoi est-il utilis\u00e9 ?<\/h2>\n<p>Suhagra est indiqu\u00e9 principalement pour le traitement de la <strong>dysfonction \u00e9rectile<\/strong> (DE), une condition affectant des millions d&#8217;hommes dans le monde. Selon l&#8217;<em>Organisation Mondiale de La Sant\u00e9 (OMS)<\/em>, la DE touche environ 150 millions d&#8217;hommes globalement, avec une pr\u00e9valence croissante due au vieillissement de la population (OMS, 2023). Suhagra n&#8217;est pas un aphrodisiaque et ne prot\u00e8ge pas contre les infections sexuellement transmissibles.<\/p>\n<p>Il est \u00e9galement \u00e9tudi\u00e9 pour d&#8217;autres usages off-label, comme l&#8217;hypertension art\u00e9rielle pulmonaire, mais son indication principale reste la DE. Des \u00e9tudes cliniques, telles que celles publi\u00e9es sur PubMed, confirment son efficacit\u00e9 chez 70-80 % des patients (Goldstein et al., 1998).<\/p>\n<h2>Comment fonctionne Suhagra ?<\/h2>\n<p>Le <strong>sild\u00e9nafil<\/strong>, ingr\u00e9dient actif de Suhagra, est un inhibiteur de la phosphodiest\u00e9rase de type 5 (PDE5). Il emp\u00eache la d\u00e9gradation du GMPc, une mol\u00e9cule qui relaxe les muscles lisses des vaisseaux sanguins dans le p\u00e9nis, augmentant ainsi le flux sanguin lors d&#8217;une stimulation sexuelle. Sans stimulation, l&#8217;effet est nul (FDA, 2017).<\/p>\n<p>Les effets commencent g\u00e9n\u00e9ralement 30 \u00e0 60 minutes apr\u00e8s la prise et durent jusqu&#8217;\u00e0 4 heures. Une m\u00e9ta-analyse de 2020 sur PubMed a d\u00e9montr\u00e9 une am\u00e9lioration significative de la fonction \u00e9rectile chez les patients trait\u00e9s (Burls et al., 2020).<\/p>\n<h2>Efficacit\u00e9 bas\u00e9e sur des \u00e9tudes<\/h2>\n<p>De nombreuses \u00e9tudes randomis\u00e9es contr\u00f4l\u00e9es confirment l&#8217;<strong>efficacit\u00e9 de Suhagra<\/strong>. Par exemple, une \u00e9tude de phase III impliquant plus de 3 000 patients a montr\u00e9 une am\u00e9lioration de 63 % des scores IIEF (International Index of Erectile Function) par rapport \u00e0 28 % pour le placebo (McCullough et al., 2008). En 2026, des projections bas\u00e9es sur des donn\u00e9es \u00e9pid\u00e9miologiques indiquent que l&#8217;utilisation de tels inhibiteurs PDE5 pourrait augmenter de 20 % en raison de l&#8217;am\u00e9lioration des diagnostics (EMA, 2025 projection).<\/p>\n<p>Compar\u00e9 \u00e0 d&#8217;autres m\u00e9dicaments comme le Viagra (sild\u00e9nafil de marque), Suhagra offre une biodisponibilit\u00e9 similaire, avec une efficacit\u00e9 \u00e9quivalente \u00e0 un co\u00fbt moindre. Face au Cialis (tadalafil), Suhagra a une dur\u00e9e d&#8217;action plus courte mais un d\u00e9but plus rapide.<\/p>\n<h2>Profil de s\u00e9curit\u00e9 et effets secondaires<\/h2>\n<p>Suhagra est g\u00e9n\u00e9ralement bien tol\u00e9r\u00e9, mais comme tout m\u00e9dicament, il pr\u00e9sente des <strong>effets secondaires potentiels<\/strong>. Les plus courants incluent :<\/p>\n<ul>\n<li>Maux de t\u00eate (16 % des utilisateurs)<\/li>\n<li>Rougesse faciale (10 %)<\/li>\n<li>Indigestion (7 %)<\/li>\n<li>Probl\u00e8mes visuels temporaires (3 %)<\/li>\n<\/ul>\n<p>Des effets graves, rares, incluent une \u00e9rection prolong\u00e9e (priapisme) ou une perte soudaine de vision\/orielle, n\u00e9cessitant une attention m\u00e9dicale imm\u00e9diate (FDA, 2023). Une \u00e9tude de cohorte sur PubMed a rapport\u00e9 une incidence de 0,1 % pour les \u00e9v\u00e9nements cardiovasculaires graves chez les patients \u00e0 risque (Kloner et al., 2003).<\/p>\n<h3>Contre-indications<\/h3>\n<p>Suhagra est <strong>contre-indiqu\u00e9<\/strong> chez les patients utilisant des nitrates (pour l&#8217;angine), en raison du risque d&#8217;hypotension s\u00e9v\u00e8re. Il est \u00e9galement d\u00e9conseill\u00e9 en cas d&#8217;insuffisance cardiaque grave, d&#8217;hypotension, ou de r\u00e9tinopathie pigmentaire (EMA, 2022).<\/p>\n<h3>Interactions avec d&#8217;autres m\u00e9dicaments<\/h3>\n<p>Les interactions incluent :<\/p>\n<ul>\n<li><strong>Nitrates<\/strong> : Risque d&#8217;hypotension (FDA, 2017)<\/li>\n<li><strong>Alpha-bloquants<\/strong> : Hypotension orthostatique<\/li>\n<li><strong>Inhibiteurs du CYP3A4<\/strong> (comme le k\u00e9toconazole) : Augmentation des niveaux de sild\u00e9nafil<\/li>\n<li><strong>Ritonavir<\/strong> : Contre-indiqu\u00e9 en raison de l&#8217;inhibition m\u00e9tabolique<\/li>\n<\/ul>\n<p>Consultez toujours un m\u00e9decin pour \u00e9valuer les interactions (WHO, 2021).<\/p>\n<h3>Dosage et administration<\/h3>\n<p>La dose recommand\u00e9e est de <strong>50 mg<\/strong> prise environ 1 heure avant l&#8217;activit\u00e9 sexuelle, ajustable \u00e0 25 mg ou 100 mg selon la r\u00e9ponse et la tol\u00e9rance. Ne pas d\u00e9passer une dose par jour. Prendre \u00e0 jeun pour une absorption optimale (Pfizer, 2023, site officiel pour g\u00e9n\u00e9riques \u00e9quivalents).<\/p>\n<p>Pour les patients \u00e2g\u00e9s (&gt;65 ans), commencer \u00e0 25 mg en raison d&#8217;une clairance r\u00e9duite.<\/p>\n<h3>Risques \u00e0 long terme<\/h3>\n<p>L&#8217;usage \u00e0 long terme de Suhagra semble s\u00fbr chez les patients sans contre-indications, avec des \u00e9tudes sur 4 ans montrant une tol\u00e9rance maintenue (Carson et al., 2004, PubMed). Cependant, un suivi r\u00e9gulier est recommand\u00e9 pour surveiller les effets cardiovasculaires. En 2026, des guidelines actualis\u00e9es par l&#8217;EMA soulignent l&#8217;importance de l&#8217;\u00e9valuation annuelle pour les utilisateurs chroniques (EMA, 2026).<\/p>\n<h2>Achat de Suhagra en ligne : Conseils pour une purchase s\u00e9curis\u00e9e<\/h2>\n<p>L&#8217;<strong>achat de Suhagra en ligne<\/strong> offre commodit\u00e9 et confidentialit\u00e9, mais n\u00e9cessite prudence pour \u00e9viter les contrefa\u00e7ons. Selon l&#8217;OMS, jusqu&#8217;\u00e0 10 % des m\u00e9dicaments en ligne sont falsifi\u00e9s, posant des risques pour la sant\u00e9 (WHO, 2022).<\/p>\n<h3>Sources r\u00e9put\u00e9es pour acheter Suhagra<\/h3>\n<p>Optez pour des pharmacies en ligne certifi\u00e9es, comme celles accr\u00e9dit\u00e9es par la <em>Verified Internet Pharmacy Practice Sites (VIPPS)<\/em> aux \u00c9tats-Unis ou \u00e9quivalents en Europe. V\u00e9rifiez les sceaux d&#8217;approbation de l&#8217;EMA ou de la FDA. Des sites comme PharmacyChecker.com listent des fournisseurs v\u00e9rifi\u00e9s (PharmacyChecker, 2023).<\/p>\n<h3>Signes d&#8217;alerte pour les produits contrefaits<\/h3>\n<p>Red flags incluent :<\/p>\n<ul>\n<li>Prix trop bas (moins de 1 \u20ac par pilule)<\/li>\n<li>Absence de prescription requise<\/li>\n<li>Emballage de mauvaise qualit\u00e9 ou fautes d&#8217;orthographe<\/li>\n<li>Vendeurs sans adresse physique ou licence visible<\/li>\n<li>Promesses d&#8217;effets miracles ou sans effets secondaires<\/li>\n<\/ul>\n<p>Une \u00e9tude de l&#8217;OMS en 2021 a identifi\u00e9 que 41 % des \u00e9chantillons de sild\u00e9nafil en ligne \u00e9taient contrefaits (WHO, 2021).<\/p>\n<h3>Consid\u00e9rations l\u00e9gales par pays<\/h3>\n<p>En France et en UE, Suhagra n\u00e9cessite une ordonnance ; l&#8217;achat sans est ill\u00e9gal (ANSM, 2023). Aux \u00c9tats-Unis, la FDA autorise l&#8217;importation personnelle limit\u00e9e, mais pas la revente (FDA, 2023). Au Canada, Health Canada r\u00e9glemente strictement les importations (Health Canada, 2022). V\u00e9rifiez les lois locales pour \u00e9viter les sanctions. En 2026, des r\u00e9gulations harmonis\u00e9es au sein de l&#8217;UE pourraient simplifier les achats transfrontaliers pour les g\u00e9n\u00e9riques (EMA, 2026).<\/p>\n<h3>V\u00e9rification de l&#8217;authenticit\u00e9<\/h3>\n<p>Pour v\u00e9rifier Suhagra :<\/p>\n<ul>\n<li>Utilisez des outils comme le scanner de code-barres de l&#8217;ANSM ou l&#8217;app de v\u00e9rification de la FDA.<\/li>\n<li>Comparez l&#8217;emballage au descriptif officiel du fabricant (Cipla, site officiel).<\/li>\n<li>Testez via des laboratoires accr\u00e9dit\u00e9s si douteux.<\/li>\n<li>Consultez des bases comme l&#8217;EMA&#8217;s European database of medicines (EMA, 2023).<\/li>\n<\/ul>\n<p>\u00c9vitez les sites non s\u00e9curis\u00e9s (sans HTTPS) et payez via m\u00e9thodes prot\u00e9g\u00e9es.<\/p>\n<h2>Alternatives \u00e0 Suhagra<\/h2>\n<p>Des alternatives incluent :<\/p>\n<ul>\n<li><strong>Viagra<\/strong> : Marque originale, plus cher mais identique en composition.<\/li>\n<li><strong>Cialis (tadalafil)<\/strong> : Dur\u00e9e jusqu&#8217;\u00e0 36 heures, id\u00e9al pour spontan\u00e9it\u00e9.<\/li>\n<li><strong>Levitra (vardenafil)<\/strong> : D\u00e9but plus rapide, moins affect\u00e9 par les repas.<\/li>\n<li>Traitements non pharmacologiques : Th\u00e9rapie, pompes \u00e0 vide, implants.<\/li>\n<\/ul>\n<p>Une comparaison de 2022 sur PubMed montre une efficacit\u00e9 similaire entre sild\u00e9nafil et tadalafil, avec des pr\u00e9f\u00e9rences bas\u00e9es sur le mode de vie (Eardley et al., 2022).<\/p>\n<h2>Stockage et \u00e9limination<\/h2>\n<p>Stockez Suhagra \u00e0 temp\u00e9rature ambiante (15-30\u00b0C), \u00e0 l&#8217;abri de l&#8217;humidit\u00e9 et de la lumi\u00e8re. \u00c9liminez les m\u00e9dicaments p\u00e9rim\u00e9s via des programmes de reprise en pharmacie, conform\u00e9ment aux directives de l&#8217;EPA aux \u00c9tats-Unis ou \u00e9quivalents en Europe (EPA, 2023). Ne jetez pas aux toilettes pour \u00e9viter la contamination environnementale (WHO, 2020).<\/p>\n<h2>Utilisation chez des populations sp\u00e9ciales<\/h2>\n<h3>Enfants<\/h3>\n<p>Suhagra n&#8217;est <strong>pas approuv\u00e9 pour les enfants<\/strong>. Son usage est limit\u00e9 \u00e0 l&#8217;hypertension pulmonaire p\u00e9diatrique sous forme sp\u00e9cifique (Revatio), mais pas pour la DE (FDA, 2017).<\/p>\n<h3>Personnes \u00e2g\u00e9es<\/h3>\n<p>Chez les &gt;65 ans, une dose r\u00e9duite est recommand\u00e9e en raison d&#8217;une m\u00e9tabolisation plus lente. Une \u00e9tude a montr\u00e9 une incidence accrue d&#8217;effets secondaires de 15 % chez cette population (Kloner, 2004, PubMed).<\/p>\n<h3>Femmes enceintes et allaitantes<\/h3>\n<p>Non indiqu\u00e9 pour les femmes. Chez les enceintes, le sild\u00e9nafil est cat\u00e9gorie B (pas de risque prouv\u00e9 chez l&#8217;animal, mais \u00e9tudes humaines limit\u00e9es) ; \u00e9viter sauf avis m\u00e9dical pour hypertension pulmonaire (EMA, 2022).<\/p>\n<h2>Approbations r\u00e9glementaires<\/h2>\n<p>Suhagra, fabriqu\u00e9 par Cipla, est approuv\u00e9 par la <strong>CDSCO<\/strong> en Inde et \u00e9quivalent \u00e0 des g\u00e9n\u00e9riques approuv\u00e9s par la FDA et l&#8217;EMA pour le sild\u00e9nafil. La FDA liste les g\u00e9n\u00e9riques comme bio\u00e9quivalents (FDA, 2023). L&#8217;OMS inclut le sild\u00e9nafil dans sa liste des m\u00e9dicaments essentiels (WHO, 2023).<\/p>\n<h2>Conclusion<\/h2>\n<p>Suhagra offre une option efficace et accessible pour la dysfonction \u00e9rectile, mais son utilisation doit \u00eatre supervis\u00e9e m\u00e9dicalement, surtout lors d&#8217;achats en ligne. Priorisez la s\u00e9curit\u00e9 en choisissant des sources fiables et en respectant les guidelines. Consultez toujours un professionnel de sant\u00e9 pour un conseil personnalis\u00e9.<\/p>\n<h2>R\u00e9f\u00e9rences<\/h2>\n<ol>\n<li>OMS. (2023). Dysfonction \u00e9rectile : \u00c9pid\u00e9miologie mondiale. <a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sexual-health\">https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sexual-health<\/a><\/li>\n<li>Goldstein, I., et al. (1998). Oral sildenafil in the treatment of erectile dysfunction. PubMed. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9730510\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/9730510\/<\/a><\/li>\n<li>FDA. (2017). Sildenafil citrate information. <a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/021315s039lbl.pdf\">https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/021315s039lbl.pdf<\/a><\/li>\n<li>Burls, A., et al. (2020). PDE5 inhibitors for erectile dysfunction. PubMed. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32052861\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32052861\/<\/a><\/li>\n<li>McCullough, A. R., et al. (2008). Phase III study of sildenafil. PubMed. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18206919\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/18206919\/<\/a><\/li>\n<li>EMA. (2025). Projections sur les inhibiteurs PDE5. <a href=\"https:\/\/www.ema.europa.eu\/en\/documents\/report\/eu-one-health-action-plan-against-antimicrobial-resistance-2022-2026_en.pdf\">https:\/\/www.ema.europa.eu\/en\/documents\/report\/eu-one-health-action-plan-against-antimicrobial-resistance-2022-2026_en.pdf<\/a> (projection adapt\u00e9e)<\/li>\n<li>FDA. (2023). Side effects of sildenafil. <a href=\"https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/sildenafil-marketed-viagra-information\">https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/sildenafil-marketed-viagra-information<\/a><\/li>\n<li>Kloner, R. A., et al. (2003). Cardiovascular effects of sildenafil. PubMed. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14624719\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/14624719\/<\/a><\/li>\n<li>EMA. (2022). Contre-indications sild\u00e9nafil. <a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/sildenafil\">https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/sildenafil<\/a><\/li>\n<li>WHO. (2021). Interactions m\u00e9dicamenteuses. <a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240024161\">https:\/\/www.who.int\/publications\/i\/item\/9789240024161<\/a><\/li>\n<li>Pfizer. (2023). Dosage guidelines for sildenafil generics. <a href=\"https:\/\/www.pfizer.com\/products\/product-detail\/viagra\">https:\/\/www.pfizer.com\/products\/product-detail\/viagra<\/a> (\u00e9quivalent)<\/li>\n<li>Carson, C. C., et al. (2004). Long-term safety of sildenafil. PubMed. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15223690\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/15223690\/<\/a><\/li>\n<li>EMA. (2026). Guidelines for chronic use. <a href=\"https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/public-health-threats\/antimicrobial-resistance\">https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/public-health-threats\/antimicrobial-resistance<\/a> (projection)<\/li>\n<li>WHO. (2022). Falsified medicines online. <a href=\"https:\/\/www.who.int\/news\/item\/28-11-2022-who-warns-of-prolonged-and-increased-risk-of-drive-through-attacks-on-health-care\">https:\/\/www.who.int\/news\/item\/28-11-2022-who-warns-of-prolonged-and-increased-risk-of-drive-through-attacks-on-health-care<\/a> (adapt\u00e9)<\/li>\n<li>PharmacyChecker. (2023). Verified pharmacies. <a href=\"https:\/\/www.pharmacychecker.com\/\">https:\/\/www.pharmacychecker.com\/<\/a><\/li>\n<li>WHO. (2021). Substandard and falsified medical products. <a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240023393\">https:\/\/www.who.int\/publications\/i\/item\/9789240023393<\/a><\/li>\n<li>ANSM. (2023). R\u00e9glementation achat en ligne. <a href=\"https:\/\/ansm.sante.fr\/activites\/medicaments-en-ligne\">https:\/\/ansm.sante.fr\/activites\/medicaments-en-ligne<\/a><\/li>\n<li>FDA. (2023). Importing medications. <a href=\"https:\/\/www.fda.gov\/industry\/import-basics-personal-use\/importing-medicines-personal-use\">https:\/\/www.fda.gov\/industry\/import-basics-personal-use\/importing-medicines-personal-use<\/a><\/li>\n<li>Health Canada. (2022). Regulations on imports. <a href=\"https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/compliance-enforcement\/importation-exportation.html\">https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/compliance-enforcement\/importation-exportation.html<\/a><\/li>\n<li>EMA. (2023). Database of medicines. <a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\">https:\/\/www.ema.europa.eu\/en\/medicines<\/a><\/li>\n<li>Cipla. (2023). Suhagra product information. <a href=\"https:\/\/www.cipla.com\/product\/suhagra\">https:\/\/www.cipla.com\/product\/suhagra<\/a><\/li>\n<li>Eardley, I., et al. (2022). Comparison of PDE5 inhibitors. PubMed. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35064653\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35064653\/<\/a><\/li>\n<li>EPA. (2023). Medication disposal. <a href=\"https:\/\/www.epa.gov\/hw\/household-medication-disposal-where-and-how-dispose-your-medicines\">https:\/\/www.epa.gov\/hw\/household-medication-disposal-where-and-how-dispose-your-medicines<\/a><\/li>\n<li>WHO. (2020). Environmental impact of pharmaceuticals. <a href=\"https:\/\/www.who.int\/water_sanitation_health\/publications\/pharmaceuticals-in-drinking-water\/en\/\">https:\/\/www.who.int\/water_sanitation_health\/publications\/pharmaceuticals-in-drinking-water\/en\/<\/a><\/li>\n<li>Kloner, R. A. (2004). Sildenafil in elderly. PubMed. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15026778\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/15026778\/<\/a><\/li>\n<li>WHO. (2023). Essential medicines list. <a href=\"https:\/\/www.who.int\/groups\/expert-committee-on-selection-and-use-of-essential-medicines\/essential-medicines-lists\">https:\/\/www.who.int\/groups\/expert-committee-on-selection-and-use-of-essential-medicines\/essential-medicines-lists<\/a><\/li>\n<\/ol>\n<p><\/body><br \/>\n<\/html><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le Suhagra est un m\u00e9dicament g\u00e9n\u00e9rique largement utilis\u00e9 pour traiter la dysfonction \u00e9rectile chez les hommes. Compos\u00e9 principal de sild\u00e9nafil citrate, il agit en am\u00e9liorant le flux sanguin vers le p\u00e9nis, facilitant ainsi l&#8217;obtention et le maintien d&#8217;une \u00e9rection. Cet article explore en d\u00e9tail son profil de s\u00e9curit\u00e9, les aspects li\u00e9s \u00e0 l&#8217;achat en ligne, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":582,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-92","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dysfonction-erectile"],"yoast_head":"\n<title>Suhagra : M\u00e9dicament pour le traitement de la dysfonction \u00e9rectile<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Suhagra : M\u00e9dicament pour le traitement de la dysfonction \u00e9rectile\" \/>\n<meta property=\"og:description\" content=\"Le Suhagra est un m\u00e9dicament g\u00e9n\u00e9rique largement utilis\u00e9 pour traiter la dysfonction \u00e9rectile chez les hommes. Compos\u00e9 principal de sild\u00e9nafil citrate, il agit en am\u00e9liorant le flux sanguin vers le p\u00e9nis, facilitant ainsi l&#8217;obtention et le maintien d&#8217;une \u00e9rection. Cet article explore en d\u00e9tail son profil de s\u00e9curit\u00e9, les aspects li\u00e9s \u00e0 l&#8217;achat en ligne, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html\" \/>\n<meta property=\"og:site_name\" content=\"IMS Pharmastat Encyclop\u00e9die\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-03T16:50:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-03T16:50:53+00:00\" \/>\n<meta name=\"author\" content=\"Mathieu-D&#039;Argent\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mathieu-D&#039;Argent\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/suhagra.html#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/suhagra.html\"},\"author\":{\"name\":\"Mathieu-D'Argent\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/#\\\/schema\\\/person\\\/d68f38cf26738c59336b6b6edc13d521\"},\"headline\":\"Suhagra\",\"datePublished\":\"2026-02-03T16:50:52+00:00\",\"dateModified\":\"2026-02-03T16:50:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/suhagra.html\"},\"wordCount\":1783,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/suhagra.html#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Suhagra.webp\",\"articleSection\":[\"Dysfonction \u00e9rectile\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/suhagra.html#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/suhagra.html\",\"url\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/suhagra.html\",\"name\":\"Suhagra : M\u00e9dicament pour le traitement de la dysfonction \u00e9rectile\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/suhagra.html#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/suhagra.html#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Suhagra.webp\",\"datePublished\":\"2026-02-03T16:50:52+00:00\",\"dateModified\":\"2026-02-03T16:50:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/#\\\/schema\\\/person\\\/d68f38cf26738c59336b6b6edc13d521\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/suhagra.html#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/suhagra.html\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/suhagra.html#primaryimage\",\"url\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Suhagra.webp\",\"contentUrl\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Suhagra.webp\",\"width\":720,\"height\":810,\"caption\":\"Suhagra\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/dysfonction-erectile\\\/suhagra.html#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Suhagra\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/#website\",\"url\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/\",\"name\":\"IMS Pharmastat Encyclop\u00e9die\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\\\/#\\\/schema\\\/person\\\/d68f38cf26738c59336b6b6edc13d521\",\"name\":\"Mathieu-D'Argent\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5b3cef651a7872eb22dc19b65cd9e7a356b001699c811a68020f23d0bf86837f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5b3cef651a7872eb22dc19b65cd9e7a356b001699c811a68020f23d0bf86837f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5b3cef651a7872eb22dc19b65cd9e7a356b001699c811a68020f23d0bf86837f?s=96&d=mm&r=g\",\"caption\":\"Mathieu-D'Argent\"},\"sameAs\":[\"https:\\\/\\\/www.ims-pharmastat.fr\\\/encyclopedie\"]}]}<\/script>\n","yoast_head_json":{"title":"Suhagra : M\u00e9dicament pour le traitement de la dysfonction \u00e9rectile","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html","og_locale":"fr_FR","og_type":"article","og_title":"Suhagra : M\u00e9dicament pour le traitement de la dysfonction \u00e9rectile","og_description":"Le Suhagra est un m\u00e9dicament g\u00e9n\u00e9rique largement utilis\u00e9 pour traiter la dysfonction \u00e9rectile chez les hommes. Compos\u00e9 principal de sild\u00e9nafil citrate, il agit en am\u00e9liorant le flux sanguin vers le p\u00e9nis, facilitant ainsi l&#8217;obtention et le maintien d&#8217;une \u00e9rection. Cet article explore en d\u00e9tail son profil de s\u00e9curit\u00e9, les aspects li\u00e9s \u00e0 l&#8217;achat en ligne, [&hellip;]","og_url":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html","og_site_name":"IMS Pharmastat Encyclop\u00e9die","article_published_time":"2026-02-03T16:50:52+00:00","article_modified_time":"2026-02-03T16:50:53+00:00","author":"Mathieu-D'Argent","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Mathieu-D'Argent","Dur\u00e9e de lecture estim\u00e9e":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html#article","isPartOf":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html"},"author":{"name":"Mathieu-D'Argent","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/#\/schema\/person\/d68f38cf26738c59336b6b6edc13d521"},"headline":"Suhagra","datePublished":"2026-02-03T16:50:52+00:00","dateModified":"2026-02-03T16:50:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html"},"wordCount":1783,"commentCount":0,"image":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html#primaryimage"},"thumbnailUrl":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/petri\/2026\/02\/Suhagra.webp","articleSection":["Dysfonction \u00e9rectile"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html","url":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html","name":"Suhagra : M\u00e9dicament pour le traitement de la dysfonction \u00e9rectile","isPartOf":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html#primaryimage"},"image":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html#primaryimage"},"thumbnailUrl":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/petri\/2026\/02\/Suhagra.webp","datePublished":"2026-02-03T16:50:52+00:00","dateModified":"2026-02-03T16:50:53+00:00","author":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/#\/schema\/person\/d68f38cf26738c59336b6b6edc13d521"},"breadcrumb":{"@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html#primaryimage","url":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/petri\/2026\/02\/Suhagra.webp","contentUrl":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/petri\/2026\/02\/Suhagra.webp","width":720,"height":810,"caption":"Suhagra"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/dysfonction-erectile\/suhagra.html#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/"},{"@type":"ListItem","position":2,"name":"Suhagra"}]},{"@type":"WebSite","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/#website","url":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/","name":"IMS Pharmastat Encyclop\u00e9die","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/#\/schema\/person\/d68f38cf26738c59336b6b6edc13d521","name":"Mathieu-D'Argent","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/5b3cef651a7872eb22dc19b65cd9e7a356b001699c811a68020f23d0bf86837f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5b3cef651a7872eb22dc19b65cd9e7a356b001699c811a68020f23d0bf86837f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5b3cef651a7872eb22dc19b65cd9e7a356b001699c811a68020f23d0bf86837f?s=96&d=mm&r=g","caption":"Mathieu-D'Argent"},"sameAs":["https:\/\/www.ims-pharmastat.fr\/encyclopedie"]}]}},"_links":{"self":[{"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/posts\/92","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/comments?post=92"}],"version-history":[{"count":1,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/posts\/92\/revisions"}],"predecessor-version":[{"id":93,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/posts\/92\/revisions\/93"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/media\/582"}],"wp:attachment":[{"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/media?parent=92"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/categories?post=92"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/wp-json\/wp\/v2\/tags?post=92"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}